These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35870026)

  • 81. Marked increase of interferon-β after BNT162b2 mRNA vaccination: a case of polyarthritis with pleurisy.
    Shimagami H; Yamaguchi Y; Kato Y; Kumanogoh A
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35236680
    [TBL] [Abstract][Full Text] [Related]  

  • 82. New acute onset of ocular myasthenia gravis after COVID-19 vaccine: A case report.
    Chaturvedi HT; Patel V; Vasava R; Chaturvedi C
    J Family Med Prim Care; 2023 Feb; 12(2):394-396. PubMed ID: 37090999
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.
    Milo R; Staun-Ram E; Karussis D; Karni A; Hellmann MA; Bar-Haim E; Miller A;
    Front Immunol; 2022; 13():868915. PubMed ID: 35432335
    [TBL] [Abstract][Full Text] [Related]  

  • 84. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Maintenance IVIg therapy in myasthenia gravis does not affect disease activity.
    Hellmann MA; Mosberg-Galili R; Lotan I; Steiner I
    J Neurol Sci; 2014 Mar; 338(1-2):39-42. PubMed ID: 24267740
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination.
    Watad A; De Marco G; Mahajna H; Druyan A; Eltity M; Hijazi N; Haddad A; Elias M; Zisman D; Naffaa ME; Brodavka M; Cohen Y; Abu-Much A; Abu Elhija M; Bridgewood C; Langevitz P; McLorinan J; Bragazzi NL; Marzo-Ortega H; Lidar M; Calabrese C; Calabrese L; Vital E; Shoenfeld Y; Amital H; McGonagle D
    Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33946748
    [TBL] [Abstract][Full Text] [Related]  

  • 87. TREATMENT OF MYASTHENIA GRAVIS PATIENTS WITH COVID-19: REVIEW OF THE LITERATURE.
    Županić S; Lazibat I; Rubinić Majdak M; Jeličić M
    Acta Clin Croat; 2022 Feb; 60(3):496-509. PubMed ID: 35282492
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation.
    Yousaf AR; Cortese MM; Taylor AW; Broder KR; Oster ME; Wong JM; Guh AY; McCormick DW; Kamidani S; Schlaudecker EP; Edwards KM; Creech CB; Staat MA; Belay ED; Marquez P; Su JR; Salzman MB; Thompson D; Campbell AP;
    Lancet Child Adolesc Health; 2022 May; 6(5):303-312. PubMed ID: 35216660
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis.
    Ciampi E; Uribe-San-Martin R; Soler B; García L; Guzman J; Pelayo C; Jürgensen L; Guzman I; Vera F; Galleguillos L; Cárcamo C
    Mult Scler Relat Disord; 2022 Mar; 59():103690. PubMed ID: 35182880
    [TBL] [Abstract][Full Text] [Related]  

  • 90. COVID-19 pandemic year in a sample of Polish myasthenia gravis patients: an observational study.
    Rzepiński Ł; Zawadka-Kunikowska M
    Neurol Neurochir Pol; 2022; 56(1):61-67. PubMed ID: 34346049
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Incidence of Cerebral Venous Thrombosis Following SARS-CoV-2 Infection vs mRNA SARS-CoV-2 Vaccination in Singapore.
    Tu TM; Yi SJ; Koh JS; Saffari SE; Hoe RHM; Chen GJ; Chiew HJ; Tham CH; Seet CYH; Yong MH; Yong KP; Hui AC; Fan BE; Tan BY; Quek AML; Seet RCS; Yeo LLL; Tan K; Thirugnanam UN
    JAMA Netw Open; 2022 Mar; 5(3):e222940. PubMed ID: 35297971
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273.
    Markewitz R; Pauli D; Dargvainiene J; Steinhagen K; Engel S; Herbst V; Zapf D; Krüger C; Sharifzadeh S; Schomburg B; Leypoldt F; Rupp J; Görg S; Junker R; Wandinger KP
    Clin Microbiol Infect; 2022 May; 28(5):701-709. PubMed ID: 34547457
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study.
    Chou CC; Su IC; Chou IJ; Lin JJ; Lan SY; Wang YS; Kong SS; Chen YJ; Hsieh MY; Hung PC; Wang HS; Chou ML; Lin KL;
    BMC Neurol; 2019 Jul; 19(1):170. PubMed ID: 31319795
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Multiple Autoimmune Syndromes Including Acute Disseminated Encephalomyelitis, Myasthenia Gravis, and Thyroiditis Following Messenger Ribonucleic Acid-Based COVID-19 Vaccination: A Case Report.
    Poli K; Poli S; Ziemann U
    Front Neurol; 2022; 13():913515. PubMed ID: 35711270
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Myasthenia gravis following human papillomavirus vaccination: a case report.
    Chung JY; Lee SJ; Shin BS; Kang HG
    BMC Neurol; 2018 Dec; 18(1):222. PubMed ID: 30593270
    [TBL] [Abstract][Full Text] [Related]  

  • 96. SARS-CoV-2 vaccine may trigger thyroid autoimmunity: real-life experience and review of the literature.
    Ruggeri RM; Giovanellla L; Campennì A
    J Endocrinol Invest; 2022 Dec; 45(12):2283-2289. PubMed ID: 35829989
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis.
    Stascheit F; Grittner U; Hoffmann S; Mergenthaler P; Schroeter M; Ruck T; Pawlitzki M; Blaes F; Kaiser J; Schara U; Della-Marina A; Thieme A; Hagenacker T; Jacobi C; Berger B; Urban PP; Knop KC; Schalke B; Lee DH; Kalischewski P; Wiendl H; Meisel A
    J Neurol; 2023 Jan; 270(1):1-12. PubMed ID: 36166068
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Ocular motility disorders following coronavirus disease-19 vaccination.
    Park KA; Jeon H; Choi DG; Jung JH; Shin HJ; Lee BJ; Moon Y; Lee SY; Lee DC; Cho SY; Kim SJ; Oh SY; Moon S; Oh SY; Choi DD; Choi MY; Kim WJ; Kim US; Lee HJ; Kim Y
    Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1127-1139. PubMed ID: 36383278
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [A case of severe inflammatory bowel disease triggered by vaccination with SARS-CoV-2 mRNA].
    Takahashi Y; Shimodaira Y; Yoshida T; Tajika M; Takahashi S; Watanabe K; Fukuda S; Koizumi S; Matsuhashi T; Iijima K
    Nihon Shokakibyo Gakkai Zasshi; 2023; 120(4):325-329. PubMed ID: 37032096
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination.
    Amiya S; Fujimoto J; Matsumoto K; Yamamoto M; Yamamoto Y; Yoneda M; Kuge T; Miyake K; Shiroyama T; Hirata H; Takeda Y; Kumanogoh A
    Int J Infect Dis; 2022 Mar; 116():255-257. PubMed ID: 35065256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.